Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, M Hosmillo, C Rees-Spear, P Mlcochova, Ines Ushiro Lumb, David J Roberts, Anita Chandra, N Temperton, The CITIID-NIHR BioResource COVID-19 Collaboration, The COVID-19 Genomics UK (COG-UK) Consortium, K Sharrocks, E Blane, JAG Briggs, MJ van Gils, KGC Smith, JR Bradley, C Smith, R Doffinger, L Ceron-Gutierrez, G Barcenas-Morales, DD Pollock, RA Goldstein, A Smielewska, JP Skittrall, T Gouliouris, IG Goodfellow, E Gkrania-Klotsas, CJR Illingworth, LE McCoy, View ORCID ProfileRK Gupta
doi: https://doi.org/10.1101/2020.12.05.20241927
SA Kemp
1Division of Infection and Immunity, University College London, London, UK
DA Collier
1Division of Infection and Immunity, University College London, London, UK
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
R Datir
1Division of Infection and Immunity, University College London, London, UK
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
IATM Ferreira
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
S Gayed
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
A Jahun
5Department of Pathology, University of Cambridge, Cambridge
M Hosmillo
5Department of Pathology, University of Cambridge, Cambridge
C Rees-Spear
1Division of Infection and Immunity, University College London, London, UK
P Mlcochova
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
Ines Ushiro Lumb
6NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK
David J Roberts
6NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK
Anita Chandra
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
N Temperton
7Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, UK
K Sharrocks
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
E Blane
3Department of Medicine, University of Cambridge, Cambridge, UK
JAG Briggs
10Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
MJ van Gils
11Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands
KGC Smith
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
JR Bradley
3Department of Medicine, University of Cambridge, Cambridge, UK
12NIHR Cambridge Clinical Research Facility, Cambridge, UK
C Smith
13Department of Virology, Cambridge University NHS Hospitals Foundation Trust
R Doffinger
15Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital
L Ceron-Gutierrez
15Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital
G Barcenas-Morales
15Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital
DD Pollock
16Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA
RA Goldstein
1Division of Infection and Immunity, University College London, London, UK
A Smielewska
5Department of Pathology, University of Cambridge, Cambridge
13Department of Virology, Cambridge University NHS Hospitals Foundation Trust
JP Skittrall
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
14Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK
17Clinical Microbiology and Public Health Laboratory, Addenbrookes’ Hospital, Cambridge, UK
T Gouliouris
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
IG Goodfellow
5Department of Pathology, University of Cambridge, Cambridge
E Gkrania-Klotsas
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK
CJR Illingworth
14Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK
18MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
LE McCoy
1Division of Infection and Immunity, University College London, London, UK
RK Gupta
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
3Department of Medicine, University of Cambridge, Cambridge, UK
19Africa Health Research Institute, Durban, South Africa
- supplementary information[supplements/241927_file05.pdf]
Posted December 29, 2020.
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, M Hosmillo, C Rees-Spear, P Mlcochova, Ines Ushiro Lumb, David J Roberts, Anita Chandra, N Temperton, The CITIID-NIHR BioResource COVID-19 Collaboration, The COVID-19 Genomics UK (COG-UK) Consortium, K Sharrocks, E Blane, JAG Briggs, MJ van Gils, KGC Smith, JR Bradley, C Smith, R Doffinger, L Ceron-Gutierrez, G Barcenas-Morales, DD Pollock, RA Goldstein, A Smielewska, JP Skittrall, T Gouliouris, IG Goodfellow, E Gkrania-Klotsas, CJR Illingworth, LE McCoy, RK Gupta
medRxiv 2020.12.05.20241927; doi: https://doi.org/10.1101/2020.12.05.20241927
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, M Hosmillo, C Rees-Spear, P Mlcochova, Ines Ushiro Lumb, David J Roberts, Anita Chandra, N Temperton, The CITIID-NIHR BioResource COVID-19 Collaboration, The COVID-19 Genomics UK (COG-UK) Consortium, K Sharrocks, E Blane, JAG Briggs, MJ van Gils, KGC Smith, JR Bradley, C Smith, R Doffinger, L Ceron-Gutierrez, G Barcenas-Morales, DD Pollock, RA Goldstein, A Smielewska, JP Skittrall, T Gouliouris, IG Goodfellow, E Gkrania-Klotsas, CJR Illingworth, LE McCoy, RK Gupta
medRxiv 2020.12.05.20241927; doi: https://doi.org/10.1101/2020.12.05.20241927
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (496)
- Anesthesia (106)
- Cardiovascular Medicine (1110)
- Dermatology (141)
- Emergency Medicine (275)
- Epidemiology (9796)
- Gastroenterology (481)
- Genetic and Genomic Medicine (2327)
- Geriatric Medicine (223)
- Health Economics (463)
- Health Informatics (1567)
- Health Policy (737)
- Hematology (238)
- HIV/AIDS (508)
- Medical Education (240)
- Medical Ethics (67)
- Nephrology (258)
- Neurology (2154)
- Nursing (134)
- Nutrition (340)
- Oncology (1185)
- Ophthalmology (366)
- Orthopedics (129)
- Otolaryngology (221)
- Pain Medicine (148)
- Palliative Medicine (50)
- Pathology (314)
- Pediatrics (699)
- Primary Care Research (268)
- Public and Global Health (4685)
- Radiology and Imaging (786)
- Respiratory Medicine (625)
- Rheumatology (276)
- Sports Medicine (212)
- Surgery (252)
- Toxicology (43)
- Transplantation (120)
- Urology (94)